Latest Strategic Shift News

Green Cross Health Limited reported a 28% rise in net profit to NZD 20.4 million for FY26, driven by gains in both pharmacy and medical divisions. The company announced a conditional sale of its Medical division to Tend Health for NZD 270 million, aiming to refocus on its core pharmacy business.

The Supreme Court of Western Australia has approved ACAM GP Limited’s full acquisition of Hartshead Resources via a scheme of arrangement, setting the stage for the company’s ASX suspension and shareholder payouts next month.

Kingston Resources stops mining at Pearse South after a second geotechnical failure, pivoting to a major underground drilling program and launching a $11.6 million capital raise to underpin a long-term expansion at Mineral Hill.

MGX Resources is set to exit its Koolan Island iron ore operation, selling to Crestlink for $20.2 million upfront plus potential revenue share, while shifting focus to gold development.

Axel REE has appointed Dr Patience Mpofu as Managing Director, positioning the company to advance its rare earths portfolio from exploration into commercial development with planned in-situ recovery trials.

Amaero Ltd has obtained Federal Court approval to re-domicile to Delaware via schemes exchanging Australian shares and options for US HoldCo equivalents, marking a major structural shift.

Saferoads Holdings (ASX: SRH) has acquired Chameleon AMLS, adding a new modular trailer product line and appointing its founder Andrew Kaye to the board.

Ryman Healthcare nearly doubles operating profitability and generates positive free cash flow for the first time in over a decade, while shifting strategy toward sustainable growth and targeting dividend returns by FY28.

Control Bionics advances its neural-signal technology across assistive communication, sports, and medical sectors, securing key US reimbursement and distribution agreements while broadening its international footprint.

FireFly Metals secures ATO Class Ruling confirming its in-specie distribution of Bellavista shares as a capital return, not a dividend, clarifying tax treatment for Australian shareholders.

Biome Australia has inked a binding deal with Specialty Probiotics Australia to shift its Activated Probiotics manufacturing onshore, aiming to boost gross margins above 65% and streamline working capital within 18 months.

AFC Group Holdings reported a sharp 78% drop in revenue to NZ$161,000 and a net loss of NZ$818,000 for FY2026, but secured shareholder backing and plans to expand its wine portfolio and distribution reach.